Breast Fine Needle Aspiration Cytology Reporting : A Study of Application of Probabilistic Approach

Size: px
Start display at page:

Download "Breast Fine Needle Aspiration Cytology Reporting : A Study of Application of Probabilistic Approach"

Transcription

1 54 Original Study Indian Medical Gazette FEBRUARY 2013 Breast Fine Needle Aspiration Cytology Reporting : A Study of Application of Probabilistic Approach Amrish N. Pandya, Professor & Head, IHBT Department, Neelam P. Shah, Resident, Pathology Department Government Medical College, Surat. Abstract Background: This study is based on application of probabilistic approach in reporting of breast fine needle aspiration cytology, its accuracy and correlation with likelihood of carcinoma in histology. Material and Method: Breast cytology was reported according to 1 of 6 categories, positive, suspicious, atypical, proliferative without atypia, unremarkable and unsatisfactory. Histologic correlation was done whenever possible. Results: Out of total 515 cases, 138 were correlated in histology. There were no false positive cases. The probability of finding carcinoma on histology, for suspicious and atypical categories was 94.11% and 75% respectively. All lesions from proliferative without atypia and unremarkable categories were benign on histology. Conclusion: The probabilistic approach is uniform, accurate method and easy to apply in reporting of breast FNAs. Suspicious and atypical categories were associated with increased incidence of carcinoma in histology and therefore such cases should be further evaluated for histology. Keywords breast carcinoma, fine needle aspiration cytology (FNAC), probabilistic approach Introduction A palpable breast lump, whether benign or malignant, is a cause of anxiety to patient. Therefore accurate pathological diagnosis is crucial for further treatment and estimation of an outcome. The trend has now been shifting to a less invasive procedure in its diagnosis. The sensitivity of FNA in diagnosis of breast lesion is % 1. Some cytologic lesions may have features mimicking to those of low grade or sparsely cellular carcinoma. Many authorities recognized this limitation of breast cytology and advised use of categorical or probabilistic approach in reporting of breast FNA to limit false positive or false negative results 2, 3, 4, 5, 6. The aim of scheme proposed by Wang and Ducatman is to categorize a lesion according to likelihood of being a carcinoma on basis of FNA finding rather than to predict precise histologic diagnosis 3. In this study we divide 3,4 breast FNAC in one out of six categories- positive, suspicious, atypical, proliferative without atypia, unremarkable and unsatisfactory; and correlate it with surgical specimen in aspects to predicting likelihood of carcinoma. Material and Method This study was ethically approved by appropriate authority. This was a cross sectional study of 482 patients with palpable breast lump. Out of these 33 patients had bilateral breast lumps. So, total 515 FNAC cases from 482 patients. Both females and males were included in this study. Metastasis in breast, cyst, abscess and fat necrosis were excluded. Out of 515 FNAC cases, 138 were correlated in histology. Remaining was not correlated in histology Address for correspondence: Dr Neelam P Shah, 4th year Resident Pathologist, Pathology Department, Government Medical College, Surat neelampshah84@gmail.com

2 Indian Medical Gazette FEBRUARY because they lost to follow-up for further management. Each patient was subjected to FNAC of breast lump under aseptic precautions after explaining the procedure and taking written consent. FNA was performed by using a 10 ml disposable syringe and 22/23-gauge needle. No local anesthesia was given during the procedure. FNA smears were stained with H & E, Pap & MGG stains. Tissue sections, obtained from mastectomy/lumpectomy specimens were stained with H and E stains. In cytology, lesions were divided according to following criteria 3, 4. c) One cell population refers to one population of atypical epithelial cells, as opposed to mix population of atypical and benign appearing epithelial cells or atypical epithelial cells and stromal cells. d) Hyper cellularity refers to atypical cell population only, rather than increased cellularity due to another component such as inflammatory or stromal cells. 2) Suspicious for carcinoma (see Fig. 2) When any three of the above features for malignancy are present, a suspicious diagnosis is given. 1) Positive for carcinoma (see Fig. 1) - all four of the following criteria must be met. Fig. 1 Smear shows positive cytology having hyper cellular smear, showing many single, loosely cohesive groups of large, pleomorphic duct cells with irregular nuclear margin & coarse chromatin and prominent nucleoli. The histologic diagnosis was infiltrating ductal carcinoma (Pap stain 1000 x) a) Cellular dyshesion refers to presence of abundant single epithelial cells or loosely cohesive groups of epithelial cells (this excludes singly bare bipolar cells and stromal cells). b) Cytologic atypia may be variable but should at least include high nuclear: cytoplasmic ratio and markedly eccentrically located nuclei. Other useful feature which may or may not be present depending on the level of pleomorphism, include nuclear membrane irregularity, coarse and clumped chromatin, multiple and irregular nucleoli. Fig. 2 Smear shows suspicious cytology, with scattered single atypical cells with eccentric nuclei. But lesion lacks hyper cellularity. The histologic diagnosis was infiltrating ductal carcinoma (H & E 1000 x) 3) Epithelial proliferative lesion with atypia (see Fig. 3) This diagnosis is made when specimen is cellular with many epithelial cells and when epithelial cells present in groups show significant crowding and overlapping and/or specimen show one other feature of malignancy (cellular dyshesion, one cell population, cellular atypia ) 4) Epithelial proliferative lesion without atypia (see Fig. 4) This category is used when a specimen is cellular with many epithelial cells and epithelial cells in group show no or mild crowding and overlapping with, obvious myoepithelial cells present. Most fibroadenoma tends to fall in this category.

3 56 Indian Medical Gazette FEBRUARY 2013 Cytologic diagnosis was correlated with surgical specimen whenever possible. Surgical specimens were classified into invasive carcinoma, ductal carcinoma in situ and benign lesion. Probability of carcinoma in histology for each category was calculated in percentages. Observations Fig. 3 Cytology smear shows proliferative breast lesion with atypia. There is cohesive groups of cells with marked crowding, overlapping and mild to moderate atypia. The histologic diagnosis was infiltrating ductal carcinoma. (MGG 400x) Table 1 shows distribution of 515 cases on aspiration cytology and histologic follow- up examination in each category. Table 2 shows correlation of cytologic and histologic diagnosis of breast FNAC along with probability of being carcinoma in histology for each category in this study. There was no false positive diagnosis on cytology. Approximately 94.11% of cases from suspicious category had carcinoma. Approximately 75% from atypical category shows carcinoma. None of the lesions from proliferative breast disease without atypia or unremarkable category shows carcinoma. Fig. 4 Cytology smear shows Proliferative breast lesion without atypia, cohesive group of cells with myoepithelial cells. There is no significant atypia or crowding/overlapping. The histologic diagnosis was fibro adenoma. (MGG 400 x) 5) Unremarkable When none of the four features of carcinoma was present, such lesions were described as unremarkable. 6) Non diagnostic/unsatisfactory If specimen is acellular or extremely hypo cellular and when it does not yield an explanation of lesion based on information provided by clinician, it was reported as unsatisfactory. Discussion Breast cancer is the commonest cancer of urban Indian women and the second commonest in the rural women next to cervical cancer. Owing to the lack of awareness of this disease and in absence of a breast cancer screening program, the majority of breast cancers are diagnosed at a relatively advanced stage 7.

4 Indian Medical Gazette FEBRUARY The rising incidence of breast cancer continues to concern. There are three main objectives for investigations in breast carcinoma, to establish correct diagnosis and staging the disease, to detect breast cancer in very early stage & to predict the prognosis. Triple diagnosis is combination of clinical examination, mammography and FNB. If all three investigations are in agreement that the lesion is either benign or malignant diagnostic accuracy is over 99%.Now, the trend has been shifting to a less invasive procedure in its diagnosis. The sensitivity of FNAC in diagnosis of breast lesion is %. Definitive treatment is often based on cytological diagnosis without histological confirmation, unless there is disagreement between cytology and clinical and/or mammographic assessment 1. Therefore a uniform reporting system with high reproducibility should be used in reporting breast FNAC. National Cancer Institute sponsored consensus conference on breast FNA biopsy in 1996, recommended the classification of breast FNAs into one out of the following 5 categories; benign, atypical, suspicious, malignant, or unsatisfactory 8. A proposal for uniform terminology and reporting of breast fine needle aspirate has provided a practical scheme for classifying breast fine needle aspiration results for reporting and management 3. The criteria proposed by Wang and Ducatman are reproducible, reduces subjectivity and offered a good frame for the implementation of quality control procedure 9. The aim of this scheme is to categorize a lesion according to likelihood of being a carcinoma on basis of FNA findings. The positive for carcinoma category has high specificity and least false positive rate. The suspicious and atypical categories serve maximum sensitivity and indicate uncertainty about diagnosis and required further diagnostic procedure. Proliferative without atypia and unremarkable categories indicate benign lesion. However if aspirate is hypo cellular it must be mentioned in report 3. A gray zone in breast cytology has long been recognized. It is in which an unequivocal diagnosis cannot be reached with fine needle aspiration cytology findings. It is due to overlapping features of benign epithelial proliferative lesion, mostly fibro adenoma, and a well differentiated carcinoma as well as borderline lesions of breast 4, 10. The gray zone in breast fine needle aspiration cytology is a broad spectrum that changes from proliferative fibrocystic disease to sclerosing adenosis to malignancy. Diagnosing gray zone pathology as atypical in fine needle

5 58 Indian Medical Gazette FEBRUARY 2013 aspiration cytology causes no delay in treatment as excision biopsy is recommended for all equivocal cases 10. The presence of nuclear pleomorphism, high nuclear: cytoplasmic ratio, epithelial cell atypia, low number of bipolar nuclei and necrosis are useful parameters to predict malignancy in atypical FNAC of breast 11. In this study, 94.11%, 75% lesions are malignant in histology from cytologic suspicious and atypical lesion respectively. Percentages of malignancy in histology from cytological suspicious and atypical lesion in various studies were shown in Table 3. management of any of these categories should base on the result of triple test. There is no false positive lesion in this study. All lesions from positive category are malignant in histology. All lesions from proliferative without atypia and unremarkable category are benign in histology. Out of 12 unsatisfactory cases, 5 cases were correlated in histology. Out of 5, one was fibro adenoma, one was atypical ductal hyperplasia and 3 were infiltrating ductal carcinoma not otherwise specified. So, unsatisfactory smears should be evaluated in conjunction with clinical and imaging appearance. Thus, this probabilistic approach in FNAC provides information about possibility of carcinoma in histology and also provides standardized guideline for breast aspiration reporting. This scheme of reporting is also applicable on male breast lesions 2. There is also interobserver agreement of this scheme of reporting on a set of breast FNAs prepared on thin prep slides 14. Summary Probabilistic approach proposed by Wang and Ducatman has definite cytologic criteria for each category. It is associated with likelihood of histologic finding of carcinoma, also accurate, easy to apply and provides a uniform approach in reporting of breast aspiration. Percentage of malignancy in atypical category is higher compared to other studies. This is because only clinically suspicious lesion in atypical category is evaluated further by histology and remaining was only followed up. Thus like other studies this study also showed that it was essential to have two less definitive categories(suspicious and atypical) and there was a definite difference between them. Possibility of carcinoma on histology for suspicious category is more than atypical cytologic category. Therefore it is worthwhile to keep these two categories separate. This study, like other studies 3, 4, 10, 12, and 13 also suggests that diagnosis of atypia is clinically significant because it is associated with increased likelihood of malignancy and such cases should be evaluated for histology. But, ultimate References 1. Karin Lindholm-Breast. Orell S.R., Sterrett G.F., Whitaker D. Fine needle aspiration cytology. 4th edition. Reed Elsevier India Private Limited, New Delhi: Chapter7, pg.167; MacIntosh R.F., Merrimen J.L., Barnes P.J. Application of the probabilistic approach to reporting Breast fine needle aspiration in males. Acta Cytol. 52: , Wang H.H., Ducatman B.S: Fine needle aspiration of the breast: a probabilistic approach to diagnosis of carcinoma. Acta Cytol. 42(2): , Ayata G., Abu-Jawdeh G.M., Fraser J.L., Garcia L.W., Upton M.P., Wang H.H. Accuracy and consistency in application of a probabilistic approach to reporting

6 Indian Medical Gazette FEBRUARY breast fine needle aspiration. Acta cytol. 47(6): , David L. Page, Joyce E. Johnson, William D. DuPont. Probabilistic approach to the reporting of fineneedle aspiration cytology of the breast. Cancer Cytopathology. 81(1): 6-9, Logrono R., Kurtycz. D.F., Inhorn S.L Criteria for reporting fine needle aspiration on palpable and non palpable masses of the breast. Acta cytol. 41(3): , Agarwal G., Ramakant P. Breast Cancer Care in India: The Current Scenario and the Challenges for the Future. Breast Care. 3(1): 21-27, [No authors listed]. The uniform approach to breast fine-needle aspiration biopsy. National Cancer Institute Fine-Needle Aspiration of Breast Workshop Sub committees. Diagn Cytopathol. 16 (4): , Francesco Feoli, Marianne Paesmans, Pascal Van Eeckhout. Fine needle aspiration cytology of breast: impact of experience on accuracy, using standardized cytologic criteria. Acta cytol. 52: , Ozkara S.K., Ustun M.O., Paksoy N. The gray zone in breast fine needle aspiration cytology. How to report on it? Acta Cytol. 46(3): , Phuong Viet The Tran, Philip C. W. Lui, Alex M. C. Yu, Pham The Vinh, Helen H. L. Chau, Tony K. F. Ma, Puay-Hoon Tan, Gary M. Tse. Atypia in fine needle aspirates of breast lesions. J Clin Pathol. 63: , Chengquan Zhao, Anwar Raza, Sue E. Martin, Jiangqiu Pan, Timothy S. Greaves, Camilla J. Cobb. Breast fine-needle aspiration samples reported as proliferative breast lesion : Clinical utility of the subcategory proliferative breast lesion with atypia Cancer Cytopathol. 117(2): , Jennifer C. Lim, Hytham Al-Masri, Alia Salhadar, H. Bill Xie, Sheryl Gabram and Eva M. Wojcik. The significance of the diagnosis of aypia in breast fine needle aspiratiom. Diagn. Cytopathol. 31(5): , Bradley Gornstein, Timothy Jacobs, Yvan Bédard, Charles Biscotti, Barbara Ducatman, Lester Layfield, Grace McKee, Nour Sneige and Helen Wang. Interobserver agreement of a probabilistic approach to reporting breast fine-needle aspirations on Thin Prep. Diagn Cytopathol. 30: , 2004.

Nicole Kounalakis, MD

Nicole Kounalakis, MD Breast Disease: Diagnosis and Management Nicole Kounalakis, MD Assistant Professor of Surgery Goal of Breast Evaluation The goal of breast evaluation is to classify findings as: normal physiologic variations

More information

Information Model Requirements of Post-Coordinated SNOMED CT Expressions for Structured Pathology Reports

Information Model Requirements of Post-Coordinated SNOMED CT Expressions for Structured Pathology Reports Information Model Requirements of Post-Coordinated SNOMED CT Expressions for Structured Pathology Reports W. Scott Campbell, Ph.D., MBA James R. Campbell, MD Acknowledgements Steven H. Hinrichs, MD Chairman

More information

MATERIALS AND METHODS: Aim of the study was to study the cytomorphological spectrum of breast lesions on Fine needle aspiration cytology (FNAC).

MATERIALS AND METHODS: Aim of the study was to study the cytomorphological spectrum of breast lesions on Fine needle aspiration cytology (FNAC). CYTOMORPHOLOGICAL STUDY OF SPECTRUM OF BREAST LESIONS AND DETERMINATION OF EFFICACY OF FNAC IN THE DIAGNOSIS OF VARIOUS BREAST LESIONS Manas Madan 1, Manisha Sharma 2, Rahul Mannan 3, Mridu Manjari 4,

More information

Diagnostic Challenge. Department of Pathology,

Diagnostic Challenge. Department of Pathology, Cytology of Pleural Fluid as a Diagnostic Challenge Paavo Pääkkö,, MD, PhD Chief Physician and Head of the Department Department of Pathology, Oulu University Hospital,, Finland Oulu University Hospital

More information

OBJECTIVES By the end of this segment, the community participant will be able to:

OBJECTIVES By the end of this segment, the community participant will be able to: Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway

More information

Evaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003

Evaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003 Evaluation and Management of the Breast Mass Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003 Common Presentations of Breast Disease Breast Mass Abnormal

More information

Cytopathology Case Presentation #8

Cytopathology Case Presentation #8 Cytopathology Case Presentation #8 Emily E. Volk, MD William Beaumont Hospital, Troy, MI Jonathan H. Hughes, MD Laboratory Medicine Consultants, Las Vegas, Nevada Clinical History 44 year old woman presents

More information

Provider Reimbursement for Women's Cancer Screening Program

Provider Reimbursement for Women's Cancer Screening Program Reimbursement Schedule July 1, 2015 June 30, 2016 Office Visits - Established Patients Office Visit / Minimal / no physician 99211 $ 16.70 Office Visit / Problem focused History / exam 99212 $ 36.46 Preventive

More information

Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer

Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer Version History Version Date Summary of Change/Process 0.1 09.01.11

More information

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred

More information

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA Breast Imaging Made Brief and Simple Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA What women are referred for breast imaging? Two groups of women are referred for

More information

Breast Ultrasound: Benign vs. Malignant Lesions

Breast Ultrasound: Benign vs. Malignant Lesions October 25-November 19, 2004 Breast Ultrasound: Benign vs. Malignant Lesions Jill Steinkeler,, Tufts University School of Medicine IV Breast Anatomy Case Presentation-Patient 1 62 year old woman with a

More information

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D. Breast Cancer: from bedside and grossing room to diagnoses and beyond Adriana Corben, M.D. About breast anatomy Breasts are special organs that develop in women during puberty when female hormones are

More information

The Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.

The Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers. Where does Molecular Analysis of FNA Specimens fit into the evaluation of thyroid nodules? The Role of Genetic Testing in the Evaluation of Thyroid Nodules Ultrasound TSH Risk factors Jill E. Langer, MD

More information

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach Kerry C. Councilman, MD Assistant Professor University of Colorado Denver Goals: BRAF Mutation

More information

MAMMOGRAPHY GOALS AND OBJECTIVES

MAMMOGRAPHY GOALS AND OBJECTIVES MAMMOGRAPHY GOALS AND OBJECTIVES GOALS: After completion of the mammography rotations, the resident will be able to: 1. Demonstrate learning of the knowledge-based objectives-(practice Base Learning) 2.

More information

Carcinosarcoma of the Ovary

Carcinosarcoma of the Ovary Carcinosarcoma of the Ovary A Rare Finding Presented By: Kathryn Kiely Anisa I. Kanbour School of Cytotechnology of the University of Pittsburgh Medical Center Pittsburgh, PA Patient History 55 year old

More information

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium Introduction 3 cavities with the same embryologic origin the mesoderme Pleura Exudates Pleura Peritoneum Pericardium 22%

More information

Classificazioni citologiche: verso uno schema internazionale unificato?

Classificazioni citologiche: verso uno schema internazionale unificato? Cytology and molecular biology for thyroid nodules diagnos6c categories to clinical ac6ons From Classificazioni citologiche: verso uno schema internazionale unificato? A. Crescenzi Diagnostic categories

More information

biopsy specimens of the breast

biopsy specimens of the breast J Clin Pathol 1994;47:329-336 Expert system support using Bayesian belief networks in the diagnosis of fine needle aspiration biopsy specimens of the breast P W Hamilton, N Anderson, P H Bartels, D Thompson

More information

Pleural and Pericardial fluids a one year analysis

Pleural and Pericardial fluids a one year analysis Pleural and Pericardial fluids a one year analysis Dr Olafsdottir Dr J Williams Department of Cytology, Llandough Hospital Contents Background Standards Aims/Questions Investigation group Results Conclusions

More information

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History

More information

The Diagnosis of Cancer in the Pathology Laboratory

The Diagnosis of Cancer in the Pathology Laboratory The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens

More information

BREAST CANCER PATHOLOGY

BREAST CANCER PATHOLOGY BREAST CANCER PATHOLOGY FACT SHEET Version 4, Aug 2013 This fact sheet was produced by Breast Cancer Network Australia with input from The Royal College of Pathologists of Australasia I m a nurse and know

More information

Pap smears, cytology and CCHC lab work and follow up

Pap smears, cytology and CCHC lab work and follow up Pap smears, cytology and CCHC lab work and follow up What is a Pap Smear? A Pap smear (also known as the Pap test) is a medical procedure in which a sample of cells from a woman's cervix (the end of the

More information

FRIEND TO FRIEND CPT CODES 2015 2016. Diagnostic digital breast tomosynthesis, unilateral (list separately in addition to code for primary procedure)

FRIEND TO FRIEND CPT CODES 2015 2016. Diagnostic digital breast tomosynthesis, unilateral (list separately in addition to code for primary procedure) FRIEND TO FRIEND CPT CODES 2015 2016 CPT CODE SERVICE DESCRIPTION FEE EFFECTIVE G0101 Screening pelvic examination $36.69 01 Jan 16 G0202 Mammography, screening, digital, bilateral (2 view film study of

More information

D. FREQUENTLY ASKED QUESTIONS

D. FREQUENTLY ASKED QUESTIONS ACR BI-RADS ATLAS D. FREQUENTLY ASKED QUESTIONS 1. Under MQSA, is it necessary to include a numeric assessment code (i.e., 0, 1, 2, 3, 4, 5, or 6) in addition to the assessment category in all mammography

More information

Non-cancerous Breast Conditions

Non-cancerous Breast Conditions Non-cancerous Breast Conditions Non-cancerous breast conditions are very common and most women have them. In fact, most breast changes that are tested turn out to be benign. Benign is another word for

More information

330 Diagnostic Cytopathology, Vol 34, No 5 # 2006 WILEY-LISS, INC.

330 Diagnostic Cytopathology, Vol 34, No 5 # 2006 WILEY-LISS, INC. Does Hurthle Cell Lesion/Neoplasm Predict Malignancy More Than Follicular Lesion/Neoplasm on Thyroid Fine-Needle Aspiration? Robert T. Pu, M.D., Ph.D., 1 * Jack Yang, M.D., 2 Patricia G. Wasserman, M.D.,

More information

Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics

Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics Wisconsin Cancer Data Bulletin Wisconsin Department of Health Services Division of Public Health Office of Health Informatics In Situ Breast Cancer in Wisconsin INTRODUCTION This bulletin provides information

More information

Recommendations for cross-sectional imaging in cancer management, Second edition

Recommendations for cross-sectional imaging in cancer management, Second edition www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Breast cancer Faculty of Clinical Radiology www.rcr.ac.uk Contents Breast cancer 2 Clinical background 2 Who

More information

Thyroid Fine-Needle Aspiration Indications and Technique. Subcommittee members Zubair W. Baloch, MD, PhD Martha Bishop Pitman, MD

Thyroid Fine-Needle Aspiration Indications and Technique. Subcommittee members Zubair W. Baloch, MD, PhD Martha Bishop Pitman, MD Thyroid Fine-Needle Aspiration Indications and Technique Subcommittee members Zubair W. Baloch, MD, PhD Martha Bishop Pitman, MD Thyroid FNA Indication Clinical Thyroid Nodule (s) > 1 cm? Hypo-functioning

More information

Intraobserver and Interobserver Reproducibility of WHO and Gleason Histologic Grading Systems in Prostatic Adenocarcinomas

Intraobserver and Interobserver Reproducibility of WHO and Gleason Histologic Grading Systems in Prostatic Adenocarcinomas International Urology and Nephrology 28 (1), pp. 73-77 (1996) Intraobserver and Interobserver Reproducibility of WHO and Gleason Histologic Grading Systems in Prostatic Adenocarcinomas $. O. OZDAMAR,*

More information

BREAST IMAGING. Developed by the Ad Hoc Committee on Resident and Fellow Education of the Society of Breast Imaging

BREAST IMAGING. Developed by the Ad Hoc Committee on Resident and Fellow Education of the Society of Breast Imaging BREAST IMAGING Developed by the Ad Hoc Committee on Resident and Fellow Education of the Society of Breast Imaging Stephen A. Feig, M.D., Chair Ferris Hall, M.D. Debra Ikeda, M.D. Ellen Mendelson, M.D.

More information

Office Visits. Breast

Office Visits. Breast Early Detection Works Reimbursement Fee Schedule Effective for services on or after July 1, 2015 Program guidelines require that be the payor of last resort. Program funds cannot be used to supplement

More information

Conflict of Interest. Overdiagnosis. Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates 4/17/2015. Jeffrey F.

Conflict of Interest. Overdiagnosis. Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates 4/17/2015. Jeffrey F. Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates Jeffrey F. Krane, MD PhD Associate Professor of Pathology Harvard Medical School Chief, Head and Neck Pathology Service Associate Director,

More information

MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15

MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15 MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases,

More information

Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid

Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_markers_in_fine_needle_aspirates_of_the_thyroid

More information

General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014

General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014 General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention

More information

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause. Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic

More information

Explanation of your PAP smear

Explanation of your PAP smear Explanation of your PAP smear Approximately 5-10% of PAP smears in the United States are judged to be abnormal. Too often, the woman who receives this news worries that she already has, or will develop,

More information

Mammography Education, Inc.

Mammography Education, Inc. Mammography Education, Inc. 2011 LÁSZLÓ TABÁR, M.D.,F.A.C.R (Hon) 3D image of a milk duct MULTIMODALITY DETECTION and DIAGNOSIS of BREAST DISEASES PRAGUE, Czech Republic Crown Plaza, Prague June 29 - July

More information

Cytodiagnosis of renal cell carcinoma A case report

Cytodiagnosis of renal cell carcinoma A case report Case Report Cytodiagnosis of renal cell carcinoma A case report Disha Singla 1, Gunvanti Rathod 2* 1 PG Student, 2 Assistant Professor Department of Pathology, SBKS MI & RC, Sumandeep Vidyapeeth, Vadodara,

More information

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Outline. Workup for metastatic breast cancer. Metastatic breast cancer Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30

More information

Cervical Cancer The Importance of Cervical Screening and Vaccination

Cervical Cancer The Importance of Cervical Screening and Vaccination Cervical Cancer The Importance of Cervical Screening and Vaccination Cancer Cells Cancer begins in cells, the building blocks that make up tissues. Tissues make up the organs of the body. Sometimes, this

More information

Writing Group for the AACE Thyroid Scientific Committee. Bernet V, Hupart KH, Parangi S and Woeber KA

Writing Group for the AACE Thyroid Scientific Committee. Bernet V, Hupart KH, Parangi S and Woeber KA Molecular Diagnostic Testing of Thyroid Nodules with Indeterminate Cytopathology Summary Highlights Writing Group for the AACE Thyroid Scientific Committee Bernet V, Hupart KH, Parangi S and Woeber KA

More information

YOUR LUNG CANCER PATHOLOGY REPORT

YOUR LUNG CANCER PATHOLOGY REPORT UNDERSTANDING YOUR LUNG CANCER PATHOLOGY REPORT 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 CONTENTS What is a Pathology Report?...3 The Basics...4 Sections of a Pathology Report...7

More information

Polyps. Hyperplasias. CAP 2011: Course AP104. The High Risk Benign Endometrium. Mutter and Nucci 1

Polyps. Hyperplasias. CAP 2011: Course AP104. The High Risk Benign Endometrium. Mutter and Nucci 1 Course AP104 Endometrial Hyperplasia A morphologic Definition Hyperplasias Hormonal Effect or Precancer? George L. Mutter, MD Harvard Medical School and Brigham and Women s Hospital Boston, MA Endometrial

More information

R-16: Chronic nonspecific cervisit

R-16: Chronic nonspecific cervisit R-16: Chronic nonspecific cervisit Ectoservikal squamous epithelium Endoservical columnar epithelium Dilated cystic endoservical glands lymphoplasmocytes R18:Squamous cell carcinoma insitu Neoplastic epithelium

More information

DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE

DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE Ryan Granger University of Rhode Island Cytotechnology program May 2, 2015 ASCT Annual Meeting Nashville, Tennessee DESMOPLASTIC SMALL ROUND

More information

EIN. (Endometrial Intraepithelial Neoplasia): Improved Criteria for diagnosing endometrial precancer. Stanley J. Robboy, MD, FCAP,

EIN. (Endometrial Intraepithelial Neoplasia): Improved Criteria for diagnosing endometrial precancer. Stanley J. Robboy, MD, FCAP, EIN (Endometrial Intraepithelial Neoplasia): Improved Criteria for diagnosing endometrial precancer Stanley J. Robboy, MD, FCAP, FFPath FRCPI (Hon), FRCPath (UK, Hon) Professor of Pathology, Duke University

More information

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT Dott. Francesco Pontieri (*) U.O. di Anatomia Patologica P.O. di Rossano (CS) Dott. Gian Franco Zannoni Anatomia Patologica Facoltà di Medicina e Chirurgia

More information

Guidance on the reporting of thyroid cytology specimens

Guidance on the reporting of thyroid cytology specimens Guidance on the reporting of thyroid cytology specimens Unique document number Document name G089 Guidance on the reporting of thyroid cytology specimens Version number 1 Produced by Date active November

More information

Fine Needle Aspiration Cytologic Features of Well-Differentiated Papillary Mesothelioma in the Pleura

Fine Needle Aspiration Cytologic Features of Well-Differentiated Papillary Mesothelioma in the Pleura The Korean Journal of Pathology 2009; 43: 583-8 DOI: 10.4132/KoreanJPathol.2009.43.6.583 Fine Needle Aspiration Cytologic Features of Well-Differentiated Papillary Mesothelioma in the Pleura - A Case Report

More information

SEMESTER VI 3 RD YEAR PATHOLOGY KIDNEY TUMORS

SEMESTER VI 3 RD YEAR PATHOLOGY KIDNEY TUMORS SEMESTER VI 3 RD YEAR PATHOLOGY KIDNEY TUMORS LEARNING OBJECTIVES At the end of the lecture, students should be able to: Know the pathology of renal tumors. RENAL TUMORS RENAL PAPILLARY ADENOMA Common

More information

VI. FREQUENTLY ASKED QUESTIONS CONCERNING BREAST IMAGING AUDITS

VI. FREQUENTLY ASKED QUESTIONS CONCERNING BREAST IMAGING AUDITS ACR BI-RADS ATLAS VI. FREQUENTLY ASKED QUESTIONS CONCERNING BREAST IMAGING AUDITS American College of Radiology 55 ACR BI-RADS ATLAS A. All Breast Imaging Modalities 1. According to the BI-RADS Atlas,

More information

Sage Screening Program. Provider Manual

Sage Screening Program. Provider Manual Sage Screening Program Provider Manual Sage Screening Program Minnesota Department of Health 85 E. 7th Place, Suite 400 P.O. Box 64882 St. Paul, Minnesota 55164-0882 (651) 201-5600 (phone) (651) 201-5601-

More information

MALE BREAST CANCER - CASE REPORT AND BRIEF REVIEW

MALE BREAST CANCER - CASE REPORT AND BRIEF REVIEW Middle East Journal of Family Medicine, 2004; Vol. 6 (6) MALE BREAST CANCER - CASE REPORT AND BRIEF REVIEW Elias A Sarru', MD, MS, AAFP, ABFP Family Physician, Al Hasa Primary Care Services Division Faysal

More information

Gladwyn Leiman, MCCCh, FIAC, FRCPath Scott Anderson, MD

Gladwyn Leiman, MCCCh, FIAC, FRCPath Scott Anderson, MD Cytology Works shop #5 Gladwyn Leiman, MCCCh, FIAC, FRCPath Scott Anderson, MD Disclosur re information The speakers have no relationship that represents a possible conflict of interest with respect to

More information

LifeProtect. Cancer Cover. For Intermediary Use Only

LifeProtect. Cancer Cover. For Intermediary Use Only LifeProtect Cancer Cover For Intermediary Use Only There are few families in Ireland that have been unaffected by cancer. In fact, 1 in 3 men and 1 in 4 women in Ireland* will suffer from cancer at some

More information

Case Report of Renal Cell Carcinoma Diagnosed in Voided Urine Confirmed by CD10 Immunocytochemistry

Case Report of Renal Cell Carcinoma Diagnosed in Voided Urine Confirmed by CD10 Immunocytochemistry Novel Insights from Clinical Practice DOI: 10.1159/000326940 Received: January 6, 2011 Accepted: February 21, 2011 Published online: July 22, 2011 Case Report of Renal Cell Carcinoma Diagnosed in Voided

More information

Case of the. Month October, 2012

Case of the. Month October, 2012 Case of the Month October, 2012 Case The patient is a 47-year-old male with a 3-week history of abdominal pain. A CT scan of the abdomen revealed a suggestion of wall thickening at the tip of the appendix

More information

MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER

MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER Renal tumours WHO 4 MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER Molecular differential pathology of renal cell tumours G. KOVACS A CLASSIFICATION BASED ON UNDERSTANDING THE GENETIC

More information

www.downstatesurgery.org

www.downstatesurgery.org Male Breast Cancer Rabih Nemr MD Kings County Hospital August 2008 ACGME Core Competencies 1 Patient t Care Medical Knowledge 2 g 3 4 Practice Based Learning/Improvement Interpersonal Communication Skills

More information

INFLAMMATION AND REACTIVE CHANGES IN CERVICAL EPITHELIUM

INFLAMMATION AND REACTIVE CHANGES IN CERVICAL EPITHELIUM INFLAMMATION AND REACTIVE CHANGES IN CERVICAL EPITHELIUM Inflammation is a response of a tissue to injury, often caused by invading microorganisms. The suffix which indicates inflammation is "-itis" (the

More information

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200 GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung

More information

Patologia neoplastica borderline della mammella"

Patologia neoplastica borderline della mammella Patologia neoplastica borderline della mammella" Anna Sapino Department of Medical Sciences University of Torino (Italy) B3 Lesion of uncertain malignant potential This category mainly consists of lesions

More information

Cervical Cancer Screening and Management Guidelines: Changing Again, Huh?

Cervical Cancer Screening and Management Guidelines: Changing Again, Huh? Cervical Cancer Screening and Management Guidelines: Changing Again, Huh? Summary of 2013 recommendations from ASC (American Cancer Society), ASCCP (American Society for Colposcopy and Cervical Pathology),

More information

Molecular Markers in Fine Needle Aspirates of the Thyroid

Molecular Markers in Fine Needle Aspirates of the Thyroid Molecular Markers in Fine Needle Aspirates of the Thyroid Policy Number: 2.04.78 Last Review: 3/2015 Origination: 3/2013 Next Review: 3/2016 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will

More information

Harlem Hospital Center Integrated Radiology Residency Program Mammography Educational goals and objectives

Harlem Hospital Center Integrated Radiology Residency Program Mammography Educational goals and objectives Harlem Hospital Center Integrated Radiology Residency Program Mammography Educational goals and objectives Rotation 1 (Radiology year 1/2) Knowledge Based Objectives: At the end of the rotation, the resident

More information

Understanding. Breast Changes. National Cancer Institute. A Health Guide for Women. National Institutes of Health

Understanding. Breast Changes. National Cancer Institute. A Health Guide for Women. National Institutes of Health National Cancer Institute Understanding Breast Changes A Health Guide for Women U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health It was easier to talk with my doctor after reading

More information

CRICO Breast Care Management Algorithm

CRICO Breast Care Management Algorithm CRICO Breast Care Management Algorithm A DECISION SUPPORT TOOL Created: 1995 Revised: 2000, 2003, 2010 Current: 2014 Warm Gray 10 PC: 20c 29m 28y 56k 7417 PC: 0c 80m 80y 0k Improving Breast Patient Safety

More information

Cytology of Lymph Nodes

Cytology of Lymph Nodes Indications Cytology of Lymph Nodes Lymph node enlargement That was easy Mary Anna Thrall Don Meuten Indications Lymph node enlargement Suspect metastasis Normal sized lymph nodes are Normal Do NOT aspirate

More information

New Wireless Handheld Ultrasound-Guided Vacuum-Assisted Breast Biopsy (VABB) Devices: An Important Innovation in Breast Diagnosis

New Wireless Handheld Ultrasound-Guided Vacuum-Assisted Breast Biopsy (VABB) Devices: An Important Innovation in Breast Diagnosis Open Journal of Radiology, 2013, 3, 174-179 Published Online December 2013 (http://www.scirp.org/journal/ojrad) http://dx.doi.org/10.4236/ojrad.2013.34029 New Wireless Handheld Ultrasound-Guided Vacuum-Assisted

More information

INTERDISCIPLINARY CONFERENCE. Florence/Firenze, Italy Nov 27-29, 2012 Centro Congressi al Duomo, Firenze BREAST SEMINAR SERIES

INTERDISCIPLINARY CONFERENCE. Florence/Firenze, Italy Nov 27-29, 2012 Centro Congressi al Duomo, Firenze BREAST SEMINAR SERIES Since breast cancer is not a systemic disease from inception, when the imagers find in situ and 1-14 mm invasive breast cancer, it is the surgeon, specialized in the treatment of breast diseases, who should

More information

Breast Sonography general goal. Optimizing Breast Sonography. BUS indications -- all. Breast Sonography specific goals.

Breast Sonography general goal. Optimizing Breast Sonography. BUS indications -- all. Breast Sonography specific goals. Optimizing general goal Cindy Rapp BS, RDMS, FAIUM, FSDMS University of Colorado Hospital Denver, Colorado to make a more specific diagnosis than can be made with clinical and mammographic findings alone

More information

Male breast cancer - Wikipedia, the free encyclopedia

Male breast cancer - Wikipedia, the free encyclopedia pagina 1 van 5 Male breast cancer From Wikipedia, the free encyclopedia Male breast cancer is a relatively rare cancer in men that originates from the breast. As it presents a similar pathology as female

More information

Frozen Section Diagnosis

Frozen Section Diagnosis Frozen Section Diagnosis Dr Catherine M Corbishley Honorary Consultant Histopathologist St George s Healthcare NHS Trust and lead examiner final FRCPath Practical 2008-2011 Frozen Section Diagnosis The

More information

Surgical guidelines for the management of breast cancer

Surgical guidelines for the management of breast cancer Available online at www.sciencedirect.com EJSO xx (2009) S1eS22 www.ejso.com Guidelines Surgical guidelines for the management of breast cancer Contents Association of Breast Surgery at BASO 2009 Introduction...

More information

How To Be A Breast Consultant Radiographer

How To Be A Breast Consultant Radiographer Overview Role of a Consultant Radiographer A reflective account Judith Kelly Peter Hogg Part 1 Clinical roles of the breast consultant radiographer Part 2 A reflection on aspects of the broader consultant

More information

Having a Breast Biopsy. A Guide for Women and Their Families

Having a Breast Biopsy. A Guide for Women and Their Families Having a Breast Biopsy A Guide for Women and Their Families Fast Facts n n Most women who have a breast biopsy do not have breast cancer. About 4 out of every 5 breast biopsies are negative for cancer.

More information

Chapter 2 Staging of Breast Cancer

Chapter 2 Staging of Breast Cancer Chapter 2 Staging of Breast Cancer Zeynep Ozsaran and Senem Demirci Alanyalı 2.1 Introduction Five decades ago, Denoix et al. proposed classification system (tumor node metastasis [TNM]) based on the dissemination

More information

THE CYTOLOGY LABORATORY

THE CYTOLOGY LABORATORY THE CYTOLOGY LABORATORY OF PATHOLOGY CASE WESTERN RESERVE UNIVERSITY AND UNIVERSITY HOSPITALS CLEVELAND, OHIO 48 THE INSTITUTE I I Motifs from medieval guilds, zodiac signs of Libra and Cancer, the urine

More information

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry M. Praet Pathology of the Pleura Normal serosa: visceral and parietal layers Inflammation Neoplasia: Primary: mesothelioma

More information

CONSOLIDATED GUIDANCE ON STANDARDS FOR THE NHS BREAST SCREENING PROGRAMME

CONSOLIDATED GUIDANCE ON STANDARDS FOR THE NHS BREAST SCREENING PROGRAMME CONSOLIDATED GUIDANCE ON STANDARDS FOR THE NHS BREAST SCREENING PROGRAMME NHSBSP Publication No 60 (Version 2) April 2005 Published by: NHS Cancer Screening Programmes The Manor House 260 Ecclesall Road

More information

The best treatment Your guide to breast cancer treatment in England and Wales

The best treatment Your guide to breast cancer treatment in England and Wales The best treatment Your guide to breast cancer treatment in England and Wales If you are looking for information on the treatment of secondary breast cancer (also known as advanced or metastatic breast

More information

ALABAMA BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM PROVIDER MANUAL

ALABAMA BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM PROVIDER MANUAL ALABAMA BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM PROVIDER MANUAL Revised January 2012 1 TABLE OF CONTENTS PROGRAM OVERVIEW.. 3 INTRODUCTION 5 SCREENING ELIGIBILITY GUIDELINES 6 PATIENT RIGHTS..

More information

Error Reduction and Prevention in Surgical Pathology. Raouf E. Nakhleh, MD Professor of Pathology Mayo Clinic Florida

Error Reduction and Prevention in Surgical Pathology. Raouf E. Nakhleh, MD Professor of Pathology Mayo Clinic Florida Error Reduction and Prevention in Surgical Pathology Raouf E. Nakhleh, MD Professor of Pathology Mayo Clinic Florida Disclosure None 2 Course Objectives At the end of the presentation participants should

More information

PROTOCOL OF THE RITA DATA QUALITY STUDY

PROTOCOL OF THE RITA DATA QUALITY STUDY PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of

More information

PART TWO: DIAGNOSING BREAST CANCER

PART TWO: DIAGNOSING BREAST CANCER PART TWO: DIAGNOSING BREAST CANCER What is Breast Cancer? Normal cells can turn into cancer because of genetic inheritance or repeated exposure to a cancer-related substance in the environment, such as

More information

Most cases of mesothelioma are caused by occupational

Most cases of mesothelioma are caused by occupational Percutaneous Image-Guided Cutting Needle Biopsy of the Pleura in the Diagnosis of Malignant Mesothelioma* Rosie F. Adams, BM BCh; Winifred Gray, MB BS; Robert J. O. Davies, DM; and Fergus V. Gleeson, MB

More information

Nilesh P. Patel, MD, 1 Cullen A. Taylor, MD, 1* Edward A. Levine, MD, 2 Jacqueline K. Trupiano, MD, 1* and Kim R. Geisinger, MD 1.

Nilesh P. Patel, MD, 1 Cullen A. Taylor, MD, 1* Edward A. Levine, MD, 2 Jacqueline K. Trupiano, MD, 1* and Kim R. Geisinger, MD 1. Anatomic Pathology / PRIMARY PERITONEAL MESOTHELIOMA Cytomorphologic Features of Primary Peritoneal Mesothelioma in Effusion, Washing, and Fine-Needle Aspiration Biopsy Specimens Examination of 49 Cases

More information

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS The evolving pathology of solitary fibrous tumours Luciane Dreher Irion MREH / CMFT / NSOPS Historical review Haemangiopericytoma (HPC) first described primarily as a soft tissue vascular tumour of pericytic

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,

More information

Mammography. What is Mammography?

Mammography. What is Mammography? Scan for mobile link. Mammography Mammography is a specific type of breast imaging that uses low-dose x-rays to detect cancer early before women experience symptoms when it is most treatable. Tell your

More information

ALTHOUGH excellent accounts have been published in recent years of

ALTHOUGH excellent accounts have been published in recent years of THE EXFOLIATIVE CYTOLOGY OF DIFFUSE MALIGNANT MESOTHELIOMA BERNARD NAYLOR Department of Pathology, University of Michigan, Ann Arbor, Michigan, U.S.A. PLATE~ LXXXVI-XCI ALTHOUGH excellent accounts have

More information

Cystic Neoplasms of the Pancreas: A multidisciplinary approach to the prevention and early detection of invasive pancreatic cancer.

Cystic Neoplasms of the Pancreas: A multidisciplinary approach to the prevention and early detection of invasive pancreatic cancer. This lecture is drawn from the continuing medical education program Finding Hope: Prevention, Early Detection and Treatment of Pancreatic Cancer, Nov, 2011. Robert P. Jury, MD Cystic Neoplasms of the Pancreas:

More information

Understanding ductal carcinoma in situ (DCIS) and deciding about treatment

Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Developed by National Breast and Ovarian Cancer Centre Funded by the Australian Government Department of Health and Ageing Understanding

More information

Data Mining Analysis (breast-cancer data)

Data Mining Analysis (breast-cancer data) Data Mining Analysis (breast-cancer data) Jung-Ying Wang Register number: D9115007, May, 2003 Abstract In this AI term project, we compare some world renowned machine learning tools. Including WEKA data

More information

Ductal carcinoma in situ (DCIS)

Ductal carcinoma in situ (DCIS) DIAGNOSIS: DCIS Ductal carcinoma in situ (DCIS) This factsheet gives information on an early form of breast cancer called ductal carcinoma in situ (DCIS). It explains what it is, how your breast is made

More information